Achaogen is dedicated to addressing serious medical needs caused by the development of bacterial resistance to antibiotics. According to the CDC, over 70% of hospital bacterial infections are resistant to one or more classes of antibacterial drugs. In the United States alone, these infections cause more than 90,000 deaths per year and result in $4.5 billion in excess healthcare costs. Achaogen exists to apply its anticipatory science to the creation of novel medical therapies to combat tomorrow’s drug-resistant pathogens, specifically, the next generation of pan-resistant bacteria, including infections caused by Gram-negative pathogens and methicillin-resistant Staphylococcus aureus (MRSA). This scientific strategy represents a novel approach to addressing the global bacterial-resistance crisis.
Company Growth (employees)
South San Francisco, US
Size (employees)
62 (est)
Achaogen was founded in 2004 and is headquartered in South San Francisco, US

Achaogen Office Locations

Achaogen has an office in South San Francisco
South San Francisco, US (HQ)
371 6000 Shoreline Ct

Achaogen Metrics

Achaogen Financial Metrics

Revenue (2016)

$41.8 m

Revenue growth (2015-16), %


Net income (2016)

($71.2 m)

Market capitalization (28-Apr-2017)

$861.6 m

Closing share price (28-Apr-2017)


Cash (31-Dec-2016)

$119 m
Achaogen's current market capitalization is $861.6 m.
Achaogen's revenue was reported to be $41.8 m in FY, 2016 which is a 60% increase from the previous period.
FY, 2014FY, 2015FY, 2016


$20 m$26.1 m$41.8 m

Revenue growth, %


R&D expense

$30.1 m$40.2 m$74 m

General and administrative expense

$9.6 m$12.4 m$17.1 m

Operating expense total

$39.8 m$52.6 m$91.1 m


($19.8 m)($26.6 m)($49.3 m)

EBIT margin, %


Interest expense

($397 k)($699 k)($2.3 m)

Net Income

($20.2 m)($27.1 m)($71.2 m)
FY, 2014FY, 2015FY, 2016


$18.9 m$20.3 m$119 m

Accounts Receivable

$301 k


$210.1 m

Current Assets

$69.4 m$65.5 m$160.3 m


$725 k$905 k$3.3 m

Total Assets

$70.3 m$66.9 m$163.9 m

Accounts Payable

$79.2 m$50.4 m

Current Liabilities

$5.5 m$8.7 m$19.7 m

Additional Paid-in Capital

$213.5 m$219.2 m$353.9 m

Retained Earnings

($148.9 m)($176 m)($247.2 m)

Total Equity

$43.2 m$106.7 m

Financial Leverage

1.5 x1.5 x
FY, 2014FY, 2015FY, 2016

Net Income

($20.2 m)($27.1 m)($71.2 m)

Depreciation and Amortization

$358 k$426 k$441 k

Cash From Operating Activities

$8.1 m$1.4 m($46.9 m)

Purchases of PP&E

($340 k)($606 k)($901 k)

Cash From Investing Activities

($45.4 m)$5.2 m$10.4 m

Cash From Financing Activities

$67.9 m$17.3 m$135.5 m

Interest Paid

$221 k$396 k$1.6 m

Achaogen Market Value History

Achaogen Online Presence

Achaogen Company Life

You may also be interested in